The Effects of Wine Consumption on Metabolic Syndrome: A Systematic Review and Meta-Analysis of Clinical Trials
Maribel Lucerón-Lucas-Torres1, María José Guzmán-Pavón2, Marta C Ruiz-Grao3
1Health and Social Research Center, University of Castilla-La Mancha, 16002 Cuenca, Spain.
Context:
Moderate alcohol use has been shown in prior research to significantly lower the risk of cardiovascular disease and metabolic syndrome. Metabolic syndrome is a major public health problem.
Objective:
The objective of this study was to analyze the effects of wine consumption on glucose, insulin, systolic blood pressure (SBP), diastolic blood pressure (DBP), and body mass index (BMI), some of the most important cardiovascular parameters associated with metabolic syndrome.
Data Sources:
To perform this systematic review and meta-analysis, we searched the MEDLINE, Scopus, Cochrane Library, and Web of Science databases from their inception until March 14, 2025.
Data Extraction:
A total of 2145 articles were identified by the search, from which 18 studies were selected for the systematic review and meta-analysis.
Data Analysis:
The DerSimonian and Laird methods were used to determine the mean differences (MDs) of the different parameters included. The risk of bias assessment was assessed via the Rob2 and ROBINS-I tools, and the Grading of Recommendations, Assessment, Development, and Evaluation tool (GRADE) certainty assessment was also performed. The pooled MD value of pre-post studies assessing the effects of wine consumption on the studied factors was -1.49 (95% CI: -3.40, 0.41) mg/dL for glucose, -1.45 (95% CI: -4.53, 1.64) μU/mL for insulin, -1.22 (95% CI: -2.08, -0.37) mmHg for SBP, -0.18 (95% CI: -2.62, 2.25) mmHg for DBP, and -0.40 (95% CI: -1.27, 0.46) kg/m2 for BMI. The pooled MD value of randomized controlled trial and crossover studies for the effect of wine on the studied factors was 1.98 (95% CI: -0.17, 4.13) mg/dL for glucose, -1.34 (95% CI: -2.27, 0.40) μU/mL for insulin, 0.10 (95% CI: -0.07, 0.26) mmHg for SBP, 0.34 (95% CI: -1.70, 2.37) mmHg for DBP, and 0.62 (95% CI: -0.31, 1.56) kg/m2 for BMI.
Conclusion:
This systematic review and meta-analysis did not reveal any effect of wine intake on glucose, insulin, DBP, or BMI; a significant effect of wine consumption on SBP was only found in pre-post studies and insulin in clinical trials. Future studies of possible effects of wine consumption on cardiovascular parameters associated with metabolic syndrome should take into account types of wine and quantities consumed.
Systematic Review Registration:
PROSPERO registration No. CRD42023396666.
More Related Videos
Related Concept Videos
01:26Atherosclerosis III: Management
01:19Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
01:30Coronary Artery Disease I: Introduction
01:29Cholesterol: Significance and Regulation
Considering cholesterol and...
01:24Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
01:19Regulation of Metabolism